Atlas Trials

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

Clinical trial NCT00466843 · UNKNOWN

Trial details

NCT number
NCT00466843
Sponsor
Office of Rare Diseases (ORD)
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome
Start date
2007-04-01
Primary completion
2010-02-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.